Zeo ScientifiX, Inc. (ZEOX)
OTCMKTS · Delayed Price · Currency is USD
1.720
+0.020 (1.18%)
Jun 16, 2026, 10:46 AM EST
Zeo ScientifiX Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 5.56 | 5.2 | 4.62 | 4.56 | 6.49 | 5.6 | |
Revenue Growth (YoY) | 21.93% | 12.53% | 1.36% | -29.78% | 15.96% | 83.18% |
Cost of Revenue | 1.02 | 0.93 | 0.84 | 0.51 | 0.75 | 0.55 |
Gross Profit | 4.53 | 4.27 | 3.78 | 4.05 | 5.74 | 5.05 |
Selling, General & Admin | 9.55 | 9.65 | 9.1 | 10.82 | 14.58 | 17.79 |
Operating Expenses | 9.55 | 9.65 | 9.1 | 10.82 | 14.58 | 17.79 |
Operating Income | -5.01 | -5.39 | -5.32 | -6.77 | -8.84 | -12.74 |
Interest Expense | -0.09 | -0.1 | -0.09 | -0.43 | -0.4 | -0.04 |
Other Non Operating Income (Expenses) | 0.07 | 0.08 | 0.1 | -0.03 | 0.22 | 0.03 |
EBT Excluding Unusual Items | -5.03 | -5.4 | -5.31 | -7.23 | -9.02 | -12.76 |
Gain (Loss) on Sale of Investments | - | - | -0.05 | -0.1 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.34 | - | - |
Other Unusual Items | -0.1 | -0.12 | 0.57 | - | - | - |
Pretax Income | -5.13 | -5.52 | -4.71 | -6.99 | -9.02 | -12.76 |
Earnings From Continuing Operations | -5.13 | -5.52 | -4.71 | -6.99 | -9.02 | -12.76 |
Earnings From Discontinued Operations | - | - | - | - | 0.13 | - |
Net Income to Company | -5.13 | -5.52 | -4.71 | -6.99 | -8.9 | -12.76 |
Net Income | -5.13 | -5.52 | -4.71 | -6.99 | -8.9 | -12.76 |
Net Income to Common | -5.13 | -5.52 | -4.71 | -6.99 | -8.9 | -12.76 |
Shares Outstanding (Basic) | 7 | 6 | 6 | 7 | 6 | 5 |
Shares Outstanding (Diluted) | 7 | 6 | 6 | 7 | 6 | 5 |
Shares Change (YoY) | 3.20% | 1.16% | -9.85% | 23.57% | 7.38% | 57.94% |
EPS (Basic) | -0.78 | -0.86 | -0.74 | -0.99 | -1.56 | -2.41 |
EPS (Diluted) | -0.78 | -0.86 | -0.74 | -0.99 | -1.56 | -2.41 |
Free Cash Flow | -1.29 | -0.74 | -1.45 | -2.22 | -3.99 | -3.11 |
Free Cash Flow Per Share | -0.20 | -0.12 | -0.23 | -0.32 | -0.70 | -0.59 |
Gross Margin | 81.62% | 82.09% | 81.73% | 88.85% | 88.39% | 90.21% |
Operating Margin | -90.21% | -103.60% | -115.13% | -148.49% | -136.23% | -227.67% |
Profit Margin | -92.35% | -106.19% | -101.84% | -153.29% | -137.06% | -227.90% |
Free Cash Flow Margin | -23.24% | -14.25% | -31.39% | -48.77% | -61.48% | -55.47% |
EBITDA | -4.94 | -5.31 | -5.25 | -6.28 | -8.51 | -12.69 |
EBITDA Margin | -88.88% | -102.19% | -113.53% | -137.82% | -131.11% | -226.73% |
D&A For EBITDA | 0.07 | 0.07 | 0.07 | 0.49 | 0.33 | 0.05 |
EBIT | -5.01 | -5.39 | -5.32 | -6.77 | -8.84 | -12.74 |
EBIT Margin | -90.21% | -103.60% | -115.13% | -148.49% | -136.23% | -227.67% |